CAS 331771-20-1 appears in our catalog under these names: ZM 447439, ZM 447439, ZM-447439/ 98.53% (existing batch purity), ZM-447439 98%, Aurora Kinase Inhibitor VI, 1PC X 5MG. Offered by: TRC, GLPBio, TargetMol, Ambeed, Sigma-Aldrich. Available pack sizes: 10mg, 25mg, 5mg, 10mM (in 1ml dmso), 50mg, 100mg, 1mg, 250mg.
ZM447439 is a member of the class of quinazolines that is quinazoline which is substituted at positions 4, 6 and 7 by a (4-benzamidophenyl)nitrilo group, methoxy group and a 3-(morpholin-4-yl)propoxy group, respectively. It is an ATP-competitive inhibitor of Aurora A and Aurora B kinases with IC50 of 110 nM and 130 nM, respectively. It has a role as an antineoplastic agent, an apoptosis inducer and an Aurora kinase inhibitor. It is a member of benzamides, an aromatic ether, a member of quinazolines, a member of morpholines, a polyether, a secondary amino compound and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C29H31N5O4 |
|---|---|
| Molecular weight | 513.6 g/mol |
| IUPAC name | N-[4-[[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]phenyl]benzamide |
| InChIKey | OGNYUTNQZVRGMN-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5 |
Computed by PubChem (NCBI)